2,4-diamino-5-benzylpyrimidine and Leukemia L5178

2,4-diamino-5-benzylpyrimidine has been researched along with Leukemia L5178 in 1 studies

*Leukemia L5178: An experimental lymphocytic leukemia of mice. [MeSH]

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dias, CB; Hansch, C; Khwaja, TA; Li, R; Selassie, CD	1

Other Studies

1 other study(ies) available for 2,4-diamino-5-benzylpyrimidine and Leukemia L5178

Article	Year
Inhibition by 5-(substituted-benzyl)-2,4-diaminopyrimidines of murine tumor (L5178Y) cell cultures sensitive to and resistant to methotrexate. Further evidence for the sensitivity of resistant cells to hydrophobic drugs. Journal of medicinal chemistry, 1982, Volume: 25, Issue:5 Topics: Animals; Antineoplastic Agents; Cells, Cultured; Chemical Phenomena; Chemistry; Chemistry, Pharmaceutical; Drug Resistance; Leukemia L5178; Leukemia, Experimental; Methotrexate; Mice; Pyrimidines; Solubility	1982

Article

Year

Inhibition by 5-(substituted-benzyl)-2,4-diaminopyrimidines of murine tumor (L5178Y) cell cultures sensitive to and resistant to methotrexate. Further evidence for the sensitivity of resistant cells to hydrophobic drugs.

Journal of medicinal chemistry, 1982, Volume: 25, Issue:5

Topics: Animals; Antineoplastic Agents; Cells, Cultured; Chemical Phenomena; Chemistry; Chemistry, Pharmaceutical; Drug Resistance; Leukemia L5178; Leukemia, Experimental; Methotrexate; Mice; Pyrimidines; Solubility

1982